Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
Biotech
Market volatility adds to 'already challenging' year for IPOs
The past week's market turbulence will likely dry up the trickle of biotech IPOs that were expected in 2025, a capital markets expert has told Fierce.
James Waldron
Apr 11, 2025 9:25am
Nasdaq plans 24-hour trading for US
Mar 7, 2025 12:32pm
Wearable defibrillator maker Kestra Medical plots $150M IPO
Feb 26, 2025 12:00pm
Kadimastem gets shareholder backing for NLS merger
Jan 31, 2025 9:42am
Metsera, Maze go public with IPOs of $275M, $113M
Jan 31, 2025 7:40am
Artificial pancreas maker Beta Bionics sets IPO goal of $120M
Jan 22, 2025 11:20am